Executive Recruiting for
Commercial Leadership in Life Sciences
The diagnostic tests, tools, devices, instruments, and therapeutics in Life Sciences are essential for conducting experiments, collecting data, analyzing biological processes, and treating patients—improving health, enhancing quality of life, and ultimately saving lives. The demand for transformational commercial leadership in these areas is more competitive than ever. Our core expertise is recruiting commercial leaders who can drive growth and innovation in this rapidly evolving landscape.
Biopharma, Biotech, Commercial Laboratories, Consumables, Devices, Esoteric Laboratories (e.g. Omics, Molecular), Equipment, Hospitals-Health Systems, Analytical Instruments, IVD, Laboratory Services, Life Sciences Tools, MedTech, Medical Device, Pathology, Therapeutics
As the infusion therapy market rapidly expands—driven by market tailwinds, regulatory stability, the growth of infusible biologics, favorable reimbursement, and a surge in chronic diseases—securing top-tier commercial leadership for Ambulatory Infusion Centers (AICs) and home infusion organizations has never been more critical. Our deep expertise in the infusion sub-sector, where Life Sciences biologics meet patient care, combined with our ability to source commercial talent from adjacent industries, sets us apart as the premier boutique commercial search firm in Infusion.
Ambulatory Infusion Centers (AICs), Home Infusion, Infusion devices and consumables, Physician Office-Based Infusion Centers (OICs), Specialty Pharmacy
Business Development
Corporate Development
General Management
Market Access (Managed Care)
Marketing
Medical Affairs
Sales
Strategy
Chief Commercial Officer
Chief Executive Officer
Chief Marketing Officer
Chief Strategy Officer
Director-Sr. Director
General Manager
Head Of
Medical Science Liaison (MSL)
Product Manager
Sales Representative (Strategic)
VP-SVP-EVP
Mike is the Co-Founder and CEO of Alder Brooks. He is a business leader and entrepreneur with a successful track record in executive search and commercial leadership, having co-founded Slone Partners and served as a Chief Commercial Officer in Life Sciences.
Mike is the Co-Founder and CEO of Alder Brooks. He is a seasoned business leader and entrepreneur with a proven track record in commercial leadership, having co-founded Slone Partners and served as a Chief Commercial Officer in Life Sciences.
Before founding Alder Brooks, Mike co-founded Wolf Hill Group, a cybersecurity executive search firm that was acquired by Slone Partners in 2022.
Earlier, Mike co-founded Slone Partners in 2000, where he excelled in various leadership roles, including Partner, Chief Operating Officer, and President. He also held VP of Sales & Marketing positions at LabCorp and Sonic Healthcare and served as Chief Commercial Officer at Pathology, Inc., backed by ABS Capital (acquired by LabCorp).
Mike graduated with honors from Le Moyne College, earned an M.A. in Applied Physiology from Columbia University, and completed his MBA at the Marshall School of Business, University of Southern California.
He is married with four children and enjoys skiing, CrossFit, and walking his Bernese Mountain Dog in the Colorado mountains.
Stephen is an Advisory Board Member of Alder Brooks and Co-Founder. Stephen was formerly a Senior Managing Director within Blackstone’s advisory business located in New York and London.
Stephen is an Advisory Board Member of Alder Brooks and Co-Founder. Stephen was formerly a Senior Managing Director within Blackstone’s advisory business located in New York and London. While at Blackstone Stephen advised the firm's corporate and sovereign clients on acquisitions, divestitures, private capital raises, and financial restructurings. Stephen began his career on Wall Street at Donaldson, Lufkin & Jenrette. In 2015 Stephen founded Acabonac Farms, a regenerative agricultural enterprise that works to better the environment and improve animal and human health.
Stephen is a graduate of The University of Pennsylvania’s Wharton School.
Stephen is married, has three children, enjoys ranching, traveling and playing blackjack.
Tim Johnson has over 25 years experience of combined healthcare private equity, M&A and financial advisory experience.
Tim Johnson has over 25 years experience of combined healthcare private equity, M&A and financial advisory experience. He has been an active investor and board member and led the growth in numerous healthcare companies including: Horizon Infusions, LabConnect Inc., BioInformatics Inc., Pathology Inc. (exited), DrugScan, Inc. and DSI Medical Services (exited), and DCL Medical Laboratories (exited).
Tim has been a Partner at BroadOak Capital, was a co-founder of Mt. Weather Capital, and founding partner of England & Company. Previously, he was an investment banker at Salomon Smith Barney, CIBC World Markets, and Friedman, Billings, Ramsey & Co. and began his career as a CPA at Arthur Andersen.
Tim earned a B.S. in Accounting (magna cum laude) and M.B.A. in Finance from the University of Maryland.
Ms. Vicki DiFrancesco is an influential leader in the laboratory industry and was formerly responsible for building and executing XiFiN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth.
Ms. Vicki DiFrancesco is an influential leader in the laboratory industry and was formerly responsible for building and executing XiFiN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth. She remains a Strategic Advisor for XiFiN after retiring in 2022 and now is also a Board Advisor for Alder Brooks.
Ms DiFrancesco was appointed as the first member of US HealthTek’s Advisory Board in March 2023 and a Non Executive Board Director for SpeeDx in September 2023.
Prior to XIFIN, Vicki served as President and CEO of Pathology Inc., the west coast’s premier women’s health laboratory that was acquired by LabCorp in March 2016. Previously, DiFrancesco was Executive Vice President of Sales and Marketing for Spectrum Laboratory Network where she grew revenues and drove expansion into new markets. She also served as Senior Vice President, Sales and Marketing for Specialty Laboratories Inc., where she oversaw marketing, customer service and was instrumental in sale of company to Ameripath in 2005.
Earlier in her career, Vicki worked as the Vice President of Hospital Sales and Marketing at Quest Diagnostics, Inc.. She has also held executive level positions with American Medical Laboratories, sold to Quest Diagnostics, and Laboratory Corporation of America. Vicki formerly served on the Board of Directors of PWNHealth, LLC, sold to Spectrum Equity.
Chris is a licensed Clinical Psychologist and the Chief Clinical Officer at Calm, playing a key role in shaping the brand’s evidence-based programs and spearheading clinical research.
Chris is a licensed Clinical Psychologist and the Chief Clinical Officer at Calm, playing a key role in shaping the brand’s evidence-based programs and spearheading clinical research. With his wealth of experience as an executive healthcare leader at Yale New Haven Health, Johnson and Johnson, Rivermend Health, Advanced Recovery Systems, Vida Health, and a Board Advisor for Alder Brooks, Chris has demonstrated his expertise in building and leading integrated healthcare services.
Chris is also a seasoned Registered Dietitian, noted for his acumen in launching and growing health-focused organizations. His thought leadership is evident in the numerous scientific publications, clinical programs, and presentations he’s developed on a variety of topics such as cognitive behavioral therapy (CBT), mental health, integrated care, obesity, eating disorders, and substance use disorders.
Chris received his undergraduate degree in Biology & Psychology from Bucknell University, his MS in Nutritional Biochemistry from Tufts, his PhD in clinical psychology from Vanderbilt, and his MBA from Yale.
